Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

NCT03445468 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
379
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Il-Yang Pharm. Co., Ltd.